Efficacy of a novel class of RNA interference therapeutic agents.
Efficacy of a novel class of RNA interference therapeutic agents.
复制标题
DOI:
10.1371/journal.pone.0042655
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Ohgi T
中科院分区:
文献类型:
--
作者:
Hamasaki T;Suzuki H;Shirohzu H;Matsumoto T;D'Alessandro-Gabazza CN;Gil-Bernabe P;Boveda-Ruiz D;Naito M;Kobayashi T;Toda M;Mizutani T;Taguchi O;Morser J;Eguchi Y;Kuroda M;Ochiya T;Hayashi H;Gabazza EC;Ohgi T
RNA interference (RNAi) is being widely used in functional gene research and is an important tool for drug discovery. However, canonical double-stranded short interfering RNAs are unstable and induce undesirable adverse effects, and thus there is no currently RNAi-based therapy in the clinic. We have developed a novel class of RNAi agents, and evaluated their effectiveness in vitro and in mouse models of acute lung injury (ALI) and pulmonary fibrosis. The novel class of RNAi agents (nkRNA®, PnkRNA™) were synthesized on solid phase as single-stranded RNAs that, following synthesis, self-anneal into a unique helical structure containing a central stem and two loops. They are resistant to degradation and suppress their target genes. nkRNA and PnkRNA directed against TGF-β1mRNA ameliorate outcomes and induce no off-target effects in three animal models of lung disease. The results of this study support the pathological relevance of TGF-β1 in lung diseases, and suggest the potential usefulness of these novel RNAi agents for therapeutic application.
登录
查看更多内容
影响因子:
46.9
作者:
Judge, AD;Sood, V;MacLachlan, I
通讯作者:
MacLachlan, I
DOI:
10.1093/nass/nrp033
发表时间:
2009-01-01
期刊:
Nucleic acids symposium series (2004)
影响因子:
--
作者:
Abe, Hiroshi;Abe, Naoko;Ito, Yoshihiro
通讯作者:
Ito, Yoshihiro
影响因子:
4.5
作者:
Reynolds, Angela;Anderson, Emily M.;Khvorova, Anastasia
通讯作者:
Khvorova, Anastasia
影响因子:
15.9
作者:
Pittet, JF;Griffiths, MJD;Sheppard, D
通讯作者:
Sheppard, D
DOI:
10.1152/ajplung.00379.2002
发表时间:
2003-12-01
影响因子:
4.9
作者:
Willis, BC;Kim, KJ;Borok, Z
通讯作者:
Borok, Z